Antibodies specific of the β-amyloid peptides and their uses as diagnostic agents or drugs
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jan 1, 2013
Grant Date -
Mar 10, 2011
app pub date -
Oct 24, 2008
filing date -
Oct 29, 2007
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
A monoclonal antibody which specifically binds to the N-terminal region of Aβ8-x peptide, x being included from 11 to 42, and recognizes neither Aβ1-40 nor Aβ1-42 and which presents a high affinity with respect to Aβ8-x peptide, such as determined by an immunological complex formation between the monoclonal antibody and the peptide Aβ8-x.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully